Papers
Topics
Authors
Recent
Search
2000 character limit reached

Toward a Team of AI-made Scientists for Scientific Discovery from Gene Expression Data

Published 15 Feb 2024 in q-bio.GN, cs.AI, and cs.LG | (2402.12391v2)

Abstract: Machine learning has emerged as a powerful tool for scientific discovery, enabling researchers to extract meaningful insights from complex datasets. For instance, it has facilitated the identification of disease-predictive genes from gene expression data, significantly advancing healthcare. However, the traditional process for analyzing such datasets demands substantial human effort and expertise for the data selection, processing, and analysis. To address this challenge, we introduce a novel framework, a Team of AI-made Scientists (TAIS), designed to streamline the scientific discovery pipeline. TAIS comprises simulated roles, including a project manager, data engineer, and domain expert, each represented by a LLM. These roles collaborate to replicate the tasks typically performed by data scientists, with a specific focus on identifying disease-predictive genes. Furthermore, we have curated a benchmark dataset to assess TAIS's effectiveness in gene identification, demonstrating our system's potential to significantly enhance the efficiency and scope of scientific exploration. Our findings represent a solid step towards automating scientific discovery through LLMs.

Definition Search Book Streamline Icon: https://streamlinehq.com
References (60)
  1. H. Abusamra. A comparative study of feature selection and classification methods for gene expression data of glioma. Procedia Computer Science, 23:5–14, 2013.
  2. A. A. Awomoyi. The human solute carrier family 11 member 1 protein (slc11a1): linking infections, autoimmunity and cancer? FEMS Immunology & Medical Microbiology, 49(3):324–329, 2007.
  3. Vitamin d: modulator of the immune system. Current opinion in pharmacology, 10(4):482–496, 2010.
  4. Chemcrow: Augmenting large-language models with chemistry tools. arXiv preprint arXiv: 2304.05376, 2023.
  5. Mammaprint™: a comprehensive review. Future oncology, 15(2):207–224, 2019.
  6. Gene: a gene-centered information resource at ncbi. Nucleic acids research, 43(D1):D36–D42, 2015.
  7. Confounding factors in the transcriptome analysis of an in-vivo exposure experiment. PLoS One, 11(1):e0145252, 2016.
  8. Personalized medicine: progress and promise. Annual review of genomics and human genetics, 12:217–244, 2011.
  9. E. Clough and T. Barrett. The gene expression omnibus database. Methods in Molecular Biology, 1418:93–110, 2016. doi: 10.1007/978-1-4939-3578-9˙5.
  10. Modulation of inflammatory and immune responses by vitamin d. Journal of autoimmunity, 85:78–97, 2017.
  11. Self-collaboration code generation via chatgpt. arXiv preprint arXiv: 2304.07590, 2023.
  12. Improving factuality and reasoning in language models through multiagent debate. arXiv preprint arXiv: 2305.14325, 2023.
  13. Towards revealing the mystery behind chain of thought: A theoretical perspective. NEURIPS, 2023.
  14. D. Ghosh and A. M. Chinnaiyan. Classification and selection of biomarkers in genomic data using lasso. Journal of Biomedicine and Biotechnology, 2005(2):147, 2005.
  15. Visualizing and interpreting cancer genomics data via the xena platform. Nature biotechnology, 38(6):675–678, 2020.
  16. What can large language models do in chemistry? a comprehensive benchmark on eight tasks. arXiv preprint arXiv:2305.18365, 2023.
  17. The path to personalized medicine. New England Journal of Medicine, 363(4):301–304, 2010.
  18. Reasoning with language model is planning with world model. Conference on Empirical Methods in Natural Language Processing, 2023. doi: 10.48550/arXiv.2305.14992.
  19. Metagpt: Meta programming for a multi-agent collaborative framework. arXiv preprint arXiv: 2308.00352, 2023.
  20. From big data to better patient outcomes. Clinical Chemistry and Laboratory Medicine (CCLM), 61(4):580–586, 2023. doi: 10.1515/cclm-2022-1096. URL https://doi.org/10.1515/cclm-2022-1096.
  21. I. M. Johnstone. On the distribution of the largest eigenvalue in principal components analysis. The Annals of statistics, 29(2):295–327, 2001.
  22. M. M. R. Khondoker. Statistical methods for pre-processing microarray gene expression data. PhD thesis, University of Edinburgh, 2006.
  23. Race, gene expression signatures, and clinical outcomes of patients with high-risk early breast cancer. JAMA Network Open, 6(12):e2349646–e2349646, 2023.
  24. Tackling the widespread and critical impact of batch effects in high-throughput data. Nature Reviews Genetics, 11(10):733–739, 2010.
  25. Theory of mind for multi-agent collaboration via large language models. arXiv preprint arXiv:2310.10701, 2023.
  26. Fast linear mixed models for genome-wide association studies. Nature methods, 8(10):833–835, 2011.
  27. Is your code generated by chatgpt really correct? rigorous evaluation of large language models for code generation, 2023.
  28. Large language models generate functional protein sequences across diverse families. Nature Biotechnology, pages 1–8, 2023.
  29. Individualization of therapy using mammaprint® ì: from development to the mindact trial. Cancer genomics & proteomics, 4(3):147–155, 2007.
  30. Skeleton-of-thought: Large language models can do parallel decoding. arXiv preprint arXiv:2307.15337, 2023.
  31. OpenAI. Gpt-4 technical report. PREPRINT, 2023.
  32. Communicative agents for software development. arXiv preprint arXiv: 2307.07924, 2023.
  33. Novel precision medicine approaches and treatment strategies in hematological malignancies. Journal of Internal Medicine, 294(4):413–436, 2023.
  34. Conceptual framework for autonomous cognitive entities. arXiv preprint arXiv: 2310.06775, 2023.
  35. Large language models encode clinical knowledge. Nature, 620(7972):172–180, 2023.
  36. Cognitive architectures for language agents. arXiv preprint arXiv: 2309.02427, 2023.
  37. Y. Talebirad and A. Nadiri. Multi-agent collaboration: Harnessing the power of intelligent llm agents. arXiv preprint arXiv: 2306.03314, 2023.
  38. R. Tibshirani. Regression shrinkage and selection via the lasso. Journal of the Royal Statistical Society Series B: Statistical Methodology, 58(1):267–288, 1996.
  39. The cancer genome atlas (tcga): an immeasurable source of knowledge. Contemporary Oncology (Poznan), 19(1A):A68–77, 2015. doi: 10.5114/wo.2014.47136.
  40. Llama: Open and efficient foundation language models. arXiv preprint arXiv: 2302.13971, 2023a.
  41. Llama 2: Open foundation and fine-tuned chat models. arXiv preprint arXiv: 2307.09288, 2023b.
  42. Gene expression profiling predicts clinical outcome of breast cancer. nature, 415(6871):530–536, 2002.
  43. Towards understanding chain-of-thought prompting: An empirical study of what matters. arXiv preprint arXiv:2212.10001, 2022a.
  44. Variable selection in heterogeneous datasets: A truncated-rank sparse linear mixed model with applications to genome-wide association studies. In 2017 IEEE International Conference on Bioinformatics and Biomedicine (BIBM), pages 431–438. IEEE, 2017.
  45. Trade-offs of linear mixed models in genome-wide association studies. Journal of Computational Biology, 29(3):233–242, 2022b.
  46. Adapting llm agents through communication. arXiv preprint arXiv: 2310.01444, 2023a.
  47. A survey on large language model based autonomous agents. arXiv preprint arXiv:2308.11432, 2023b.
  48. Self-consistency improves chain of thought reasoning in language models. arXiv preprint arXiv:2203.11171, 2022c.
  49. Unleashing the emergent cognitive synergy in large language models: A task-solving agent through multi-persona self-collaboration. arXiv preprint arXiv:2307.05300, 2023c.
  50. Chain-of-thought prompting elicits reasoning in large language models. Advances in Neural Information Processing Systems, 35:24824–24837, 2022.
  51. Genome-wide association analysis by lasso penalized logistic regression. Bioinformatics, 25(6):714–721, 2009.
  52. Auto-gpt for online decision making: Benchmarks and additional opinions. arXiv preprint arXiv: 2306.02224, 2023a.
  53. An overview of the use of precision population medicine in cancer care: First of a series. Cureus, 15(4), 2023b.
  54. Large language models in health care: Development, applications, and challenges. Health Care Science, 2(4):255–263, 2023c.
  55. React: Synergizing reasoning and acting in language models. arXiv preprint arXiv:2210.03629, 2022.
  56. Socs1 and its potential clinical role in tumor. Pathology & Oncology Research, 25(4):1295–1301, 2019.
  57. A unified mixed-model method for association mapping that accounts for multiple levels of relatedness. Nature genetics, 38(2):203–208, 2006.
  58. Synapse: Leveraging few-shot exemplars for human-level computer control. arXiv preprint arXiv:2306.07863, 2023.
  59. How far are large language models from agents with theory-of-mind? arXiv preprint arXiv: 2310.03051, 2023a.
  60. Agents: An open-source framework for autonomous language agents. arXiv preprint arXiv:2309.07870, 2023b.
Citations (1)

Summary

  • The paper introduces TAIS, a multi-agent system using LLMs to automate gene expression analysis and predict disease-associated genes.
  • It employs Lasso regression with eigenvalue gap analysis to isolate predictive genes while accounting for confounding factors such as age and gender.
  • Benchmarking on the GenQEX dataset demonstrates TAIS's competitive precision and recall, highlighting potential for enhancing personalized treatment strategies.

Toward a Team of AI-made Scientists for Scientific Discovery from Gene Expression Data

Introduction

In the pursuit of advancing scientific discovery through automation, gene expression datasets have been identified as crucial for understanding disease-predictive genes, especially for complex diseases such as cancer. Traditional methods of gene analysis require significant human expert intervention in dataset selection, processing, and analysis. This paper proposes a framework, a Team of AI-made Scientists (TAIS), to automate and streamline these processes using a multi-agent system composed of various roles modeled by LLMs. These roles mimic human scientists working collaboratively to predict disease-associated genes more efficiently.

System Architecture

TAIS is structured to simulate the collaborative dynamics of a human research team comprising five key roles: Project Manager, Data Engineer, Domain Expert, Statistician, and Code Reviewer. Each role is fulfilled by an LLM acting as an agent responsible for specific tasks.

The Project Manager initiates the setup, decomposing the overarching problem into manageable subtasks aligned with each role's capabilities. For example, gene data preprocessing tasks are assigned to the Data Engineer, who collaborates with the Domain Expert for technical guidance. Meanwhile, the Statistician, supported by the Code Reviewer, carries out regression analyses on processed datasets. Figure 1

Figure 1: The overview of the Team of the AI-made Scientists (TAIS). The illustration starts from the top right corner where the user uses the system. The question goes to the project manager. The project manager further decomposes the tasks and assigns tasks to different AI-made scientists, illustrated in the yellow area. The blue area shows the details of how the statistician analyzes the data.

Collaboration and Task Execution

The collaboration among agents is pivotal for ensuring task precision. The Data Engineer, while performing data preprocessing, frequently interfaces with the Domain Expert to obtain contextual understanding crucial for tasks involving complex datasets from public repositories like GEO and TCGA. This interaction ensures the accurate handling of biomedical terminologies and experimental setups. Figure 2

Figure 2

Figure 2: The collaboration between Data Engineer and Code Reviewer.

Additionally, the program-and-review dynamic between the Data Engineer, Statistician, and Code Reviewer is essential. Code Reviewer evaluates all produced code for adherence to standards and scientific rigour, providing iterative feedback to resolve any issues before proceeding.

Regression Analysis for Gene Identification

The regression model used within TAIS adapts Lasso regression for variable selection from high-dimensional gene expression data. This model efficiently isolates predictive genes by suppressing less informative features. Confounding factor detection is done via eigenvalue gap analysis of the covariance matrix, guiding decisions on correction processes during regression.

The incorporation of external conditions such as age and gender is modeled by extending the basic regression framework to include these variables as additional matrices, allowing TAIS to further refine gene-disease relationships.

Benchmark Creation and Evaluation

To assess TAIS's capability, a benchmark dataset titled Genetic Question Exploration (GenQEX) was developed, including 457 trait-condition pairs derived from a pre-defined list of biomedical entities. These questions directed TAIS to identify predictive genes while considering various potential confounding diseases or demographic factors.

Results and Discussion

TAIS effectively streamlined the discovery of disease-predictive genes, showing competitive precision and recall across various complex scenarios. While the system outperformed traditional methods requiring heavy manual input, particular challenges remain in fully realizing the potential of multi-step and two-step regression analyses.

The case study on Pancreatic Cancer with Vitamin D Levels demonstrated TAIS's proficiency in identifying genes validated by existing biomedical literature. This achievement emphasizes the potential of TAIS to enhance personalized treatment strategies by providing insights into how conditions affect gene-disease relationships.

Conclusion

This paper presents a novel framework through TAIS, using LLM agents to automate labor-intensive elements of scientific research. The implementation highlights steps towards reducing human dependency in data analysis workflows. While promising, continued improvement and expansion of capabilities are necessary to address limitations inherent in fully automated scientific discovery systems. The benchmark provides a solid foundation for future methods to compare and enhance upon TAIS's existing framework.

Whiteboard

No one has generated a whiteboard explanation for this paper yet.

Open Problems

We haven't generated a list of open problems mentioned in this paper yet.

Collections

Sign up for free to add this paper to one or more collections.

Tweets

Sign up for free to view the 1 tweet with 0 likes about this paper.